Sign in

You're signed outSign in or to get full access.

Jason Groves

Chief Legal Officer & Corporate Secretary at MEDIFASTMEDIFAST
Executive

About Jason Groves

Jason L. Groves, Esq., 54, is Medifast’s Chief Legal Officer & Corporate Secretary, overseeing the Office of the Chairman and the legal function (compliance, litigation, regulatory, government relations) since joining the company in 2009 . He previously served on Medifast’s Board as an independent director (2009–2011) and Executive Committee member (2011–2015) . Prior roles include Assistant Vice President of Government Affairs at Verizon Maryland and service as a U.S. Army JAG officer and Special Assistant U.S. Attorney for three years, earning multiple commendations . Company performance alignment indicators: 2022–2024 PSUs did not vest due to falling short of cumulative revenue and operating income targets, and 2024 adjusted operating income reached $49.8M; annual incentive paid at 49% of target, signaling tighter pay-for-performance linkage amid transformation initiatives .

Past Roles

OrganizationRoleYearsStrategic Impact
Medifast, Inc.Director; Independent Director (Audit Committee); Executive Committee member2009–2015Governance oversight; committee leadership supporting corporate strategy and compliance
Medifast, Inc.Executive legal leadership roles prior to CLOSince 2009Built and led compliance, litigation, regulatory, and government relations capabilities

External Roles

OrganizationRoleYearsStrategic Impact
Verizon MarylandAssistant Vice President, Government AffairsNot disclosedLed legislative policy and government affairs for the company in Maryland
U.S. Army (JAG Corps)Judge Advocate; Special Assistant U.S. Attorney3 years (dates not disclosed)Prosecutorial and legal service; earned Army Achievement and Army Commendation Medals

Fixed Compensation

Metric2022 (USD)2023 (USD)2024 (USD)
Base Salary$411,286 $427,781 $427,781
Target Bonus % of Salary70% 70% 70%
All Other Compensation$12,683 $54,866 $14,349
Total Compensation$1,158,643 $1,632,144 $1,094,793

Notes:

  • Base salaries for all NEOs were held flat in 2024 (second consecutive year) in line with austerity measures .
  • All other compensation in 2024 primarily reflects $13,800 401(k) match; health savings contributions and group term life insurance .

Performance Compensation

Annual Incentive (2024 design and outcomes)

MetricWeightThresholdTarget / MaxActualPayout (Plan)
Q3 Coach Productivity (New Customers per AEC)20% 0.95 1.42 1.05 Not disclosed by metric; overall plan paid 49% of target
Q4 Coach Productivity (New Customers per AEC)20% 0.74 1.26 0.85 Not disclosed by metric; overall plan paid 49% of target
Transformation Initiatives (Company-led acquisition channel; dual offer launch)35% Launch initiatives Launch initiatives 23% achievement Not disclosed by metric; overall plan paid 49% of target
Operating Income (before investments and one-time items, $M)25% $2.70 $17.60 $49.8 (adjusted, non-GAAP) Not disclosed by metric; overall plan paid 49% of target
Overall Annual Incentive Payout49% of target for all NEOs

Design notes:

  • 2024 payout range reduced to 25%–100% of target (from 50%–150% in 2023) to reflect financial/operational conditions .
  • Metrics combined quantitative (productivity, operating income) and qualitative transformation execution .

Long-Term Incentives (2024 grants)

Award TypeGrant DateTarget SharesVesting / Performance Conditions
Time-Based RSUs03/13/20247,076 Vests ratably over 3 years (2025–2027)
Performance Share Units (PSUs)03/13/20247,076 3 one-year performance periods, averaged; Year 1 earnout: 25%–150%; Years 2–3: 25%–200%; PSU distribution after 3-year period ending 12/31/2026; metric: revenue growth

Historical PSU outcome:

  • 2022–2024 PSU program paid 0% (no vest) as cumulative revenue ($3,272,631k) and operating income ($404,968k) fell below threshold targets .

Grants of Plan-Based Awards (Cash and Equity, 2024)

ItemThresholdTargetMaximum
2024 Annual Incentive (Cash)$74,862 $299,447 $299,447
2024 PSUs (shares)1,769 7,076 12,972
2024 RSUs (shares)7,076

Equity Ownership & Alignment

Ownership DetailValue
Beneficial Ownership (shares)13,909; <1% of outstanding shares
Unvested RSUs at 12/31/2024347; 2,475; 7,076 (by grant; see schedule below)
Unvested PSUs at 12/31/20243,712 (vesting 12/31/2025); 7,076 (vesting 12/31/2026)
Options OutstandingNone (no options listed for Groves)
Stock Ownership GuidelinesDirect reports to CEO: 3x annual salary; 50% of net shares must be held until compliant
Anti-hedging & Anti-pledgingHedging and pledging prohibited for officers/directors
Clawback PolicyDodd‑Frank/NYSE-compliant; 3-year restatement recoupment; fiduciary breach recoupment provisions
Section 16(a) ComplianceAll reports timely filed in 2024

Vesting Schedules (near-term supply signals)

GrantTypeVesting Date(s)Shares
03/16/2022RSU03/16/2025347
03/17/2023RSU03/17/2025; 03/17/20261,237; 1,238
03/13/2024RSU03/13/2025; 03/13/2026; 03/13/20272,358; 2,359; 2,359
03/16/2022PSU12/31/20253,712 (at target, subject to performance)
03/13/2024PSU12/31/20267,076 (at target, subject to performance)

Policy alignment:

  • Dividends on equity accrue/pay only upon vesting .
  • No repricing; double-trigger change-in-control protections in share plan .

Employment Terms

ProvisionStandardGroves-specific (estimated payout values at 12/31/2024 share price)
Severance (no-Cause / Good Reason)1x salary + target bonus; pro‑rated bonus; pro‑rata vesting of RSUs/PSUs; option acceleration Severance $727,228; Annual Bonus $146,729; Unvested RSUs $52,109; Unvested PSUs $66,591
Change-in-Control (double-trigger)1.5x salary + target bonus (2.5x for CEO); greater of target or actual for pro‑rated bonus; equity acceleration/pro‑rata PSU vesting Severance $1,090,842; Annual Bonus $299,447; Unvested RSUs $174,403; Unvested PSUs $85,163
Tax Gross-ups (280G)Officers not eligible Not eligible
Non-compete/Non-solicitNot disclosed in proxyNot disclosed
Garden Leave/ConsultingNot disclosedNot disclosed

Change-in-control equity terms (2012 Plan):

  • Double-trigger vesting if awards assumed and the executive is terminated without cause within 24 months; otherwise full vest on CIC if not assumed .

Investment Implications

  • Pay-for-performance alignment: 2022–2024 PSUs paid 0% due to performance shortfalls; 2024 annual incentive paid 49% of target, aligning realized pay to execution progress amid transformation; 2024 LTI mix emphasizes PSUs (50%) and RSUs (50%) for NEOs, focusing future payout on revenue growth .
  • Retention vs guaranteed pay: Base salary held flat for 2023–2024, with incremental LTI grant in lieu of a merit increase, increasing retentive equity holding power while preserving at-risk structure .
  • Selling pressure: Near-term RSU vests in March 2025–2027 total ~6,304 shares; PSU vest outcomes are performance-contingent (Dec 2025 and Dec 2026), which moderates forced selling risk relative to time-based vests; anti-hedging and anti-pledging policies further reduce pressure .
  • Ownership alignment: Personal share ownership is <1% of outstanding; strong company-wide ownership guidelines (3x salary for direct reports) require continued net share retention until compliant, promoting alignment despite low absolute stake .
  • Change-of-control economics: Double-trigger severance and equity acceleration provide meaningful protection without 280G gross-ups; values at 12/31/2024 imply substantial benefits but are within market norms and plan limits .

Additional Reference

  • Say‑on‑Pay support: ~96% approval at 2024 annual meeting for the Company’s executive compensation program decisions, indicating shareholder endorsement of design and direction .
  • Peer benchmarking & burn rate: Peer group maintained in 2024; Company three‑year average burn rate ~1.56%; overhang ~9.1% (would be ~13% with proposed share increase), with strong governance features (no evergreen, no repricing, minimum vesting) .

Overall, Groves’ package is structured to be primarily at-risk with multi-year PSU hurdles and meaningful clawback protections. Near-term RSU vesting should be monitored for potential 10b5‑1 activity, but policy constraints (anti-hedging/pledging) and performance gating on PSUs point to limited involuntary selling pressure. Severance/CIC terms are protective yet shareholder-friendly (no gross-ups), supporting retention through the transformation period .